Beckman CEO Resigns As Company Faces Regulatory Challenges
This article was originally published in The Gray Sheet
Executive Summary
Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny
You may also be interested in...
People In Brief
Cook Group founder dies, son takes helm
People In Brief
Cook Group founder dies, son takes helm
Danaher Buys Beckman: Fixing Quality Issues, Cutting Costs Are Priorities
Danaher’s priorities for its newly acquired Beckman Coulter diagnostics business will include cutting $250 million in costs, completing quality control fixes already underway and getting certain cardiac troponin assays back on the market.